Human Cancerous Inhibitor Of PP2A (CIP2A) ELISA Kit

Quantitative measurement of cancerous inhibitor of PP2A in human samples supports oncology and cell signaling research. Assay Genie provides this kit in a 96-assay configuration, suitable for studies investigating PP2A pathway dysregulation across multiple cancer types.

CIP2A, encoded by the KIAA1524 gene, suppresses protein phosphatase 2A activity and is documented as overexpressed in gastric, hepatocellular, and head and neck squamous cell carcinomas. Researchers deploy this reagent to quantify biomarker levels across clinical human specimens from patient cohorts and preclinical experimental systems.

Each kit contains pre-coated plate wells, detection antibodies, recombinant standards, substrate, and stop solution distributed in individual vials. Reconstituted components are intended for research use only and should be stored at 4°C until first use to preserve antibody binding activity and reagent stability.

Workflow steps include standard dilution, sample incubation, washing, enzyme conjugate addition, and a final absorbance reading following stop solution. The microplate supports medium-throughput screens of clinical or preclinical sample sets when standards are run in duplicate across the 96 assay positions.